论文信息 - BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initiating Cells with Differential Regulation of Relevant Genes Leading to Extended Survival in a NRAS/BCL-2 Mouse Model of High Risk-Myelodysplastic Syndrome - 字舞流文

BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initiating Cells with Differential Regulation of Relevant Genes Leading to Extended Survival in a NRAS/BCL-2 Mouse Model of High Risk-Myelodysplastic Syndrome

P. Merlet | M. Konopleva | M. Andreeff | L. Sarda-Mantel | P. Fenaux | N. Tekin | L. Adès | N. Setterblad | M. Pla | P. de la Grange | A. Janin | C. Chomienne | J. Boultwood | A. Pellagatti | S. Ganesan | N. Omidvar | Laure Goursaud | F. Guidez | C. Leboeuf | Satyananda Patel | R. Padua | L. Guerenne | Stéphanie Beurlet | P. Gorombei | C. le Pogam | M. Noguera | P. Krief | R. West | Mathieu Chiquet